Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.10
- Piotroski Score 3.00
- Grade Overweight
- Symbol (BRKR)
- Company Bruker Corporation
- Price $56.58
- Changes Percentage (0.64%)
- Change $0.36
- Day Low $56.17
- Day High $57.47
- Year High $94.86
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
- Last Earnings 11/18/2024
- Ex-Dividend for 5/16 Dividend 12/02/2024
- Dividend Payable 12/16/2024
- Today N/A
- Next Earnings (Estimated) 01/06/2025
- Fiscal Year End N/A
- Average Stock Price Target $77.50
- High Stock Price Target $80.00
- Low Stock Price Target $60.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $2.73
- Trailing P/E Ratio 23.7
- Forward P/E Ratio 23.7
- P/E Growth 23.7
- Net Income $427.20 M
Income Statement
Quarterly
Annual
Latest News of BRKR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Is Bruker Corporation (BRKR) the Most Profitable Mid-Cap Stock to Invest In Now?
The article discusses the market decline due to inflation concerns, with insights from experts like Luke O'Neill and Atlanta Fed President Raphael Bostic. It highlights the potential impact on small- ...
By Yahoo! Finance | 1 month ago -
Bruker's (NASDAQ:BRKR) 7.1% CAGR outpaced the company's earnings growth over the same five-year period
Despite recent stock price decline, Bruker Corporation has shown positive long-term growth. Share price increased by 39% in five years, exceeding market return. The company's EPS growth outpaced share...
By Yahoo! Finance | 5 months ago
